BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200909
DTEND;VALUE=DATE:20200911
DTSTAMP:20260405T141524
CREATED:20200819T141833Z
LAST-MODIFIED:20200820T183034Z
UID:4281-1599609600-1599782399@carb-x.org
SUMMARY:PACCARB: Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
DESCRIPTION:The September PACCARB meeting\, held virtually\, will focus on welcoming eight new liaison members and on the impact of COVID-19 and its affect on antimicrobial resistance (AMR). Topics will include presentations on the COVID-19 mortality rate due to secondary acquired infections\, antibiotic stewardship practices during a pandemic\, disruptions in the agricultural industry due to COVID-19 and the intersection of AMR and emergency preparedness. \nThis virtual public meeting is hosted by HHS and is open to the public. It will be held via webcast.The meeting can be accessed through a live webcast on the day of the meeting. \nLive Webcast: www.hhs.gov/live\nClick here to learn more.
URL:https://carb-x.org/event/paccarb-presidential-advisory-council-on-combating-antibiotic-resistant-bacteria/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200917T140000
DTEND;TZID=America/New_York:20200917T153000
DTSTAMP:20260405T141524
CREATED:20200916T133131Z
LAST-MODIFIED:20200916T133131Z
UID:4337-1600351200-1600356600@carb-x.org
SUMMARY:Building\, Funding\, and Growing Successful Biotech Startups
DESCRIPTION:Speakers include Cameron Bess\, Project Officer\, Antibacterials Branch\, Division of CBRN Medical Countermeasures\, BARDA. \nTurning a good scientific idea into a successful biotech startup is a challenging journey.This panel will highlight several successful paths that scientists can take toward creating a successful biotech company. Learn what New York-area resources are available to turn your idea into a business and help you develop entrepreneurial skills. \nThe event will introduce funding and strategic programs available from IndieBio\, the Center for Biotechnology\, the National Institutes of Health (NIH)\, and the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). \nSpeakers include: \n\nAnton Xavier\, Assistant Director of Technology and Business Development at the Center for Biotechnology.\nPhuong Nguyen\, Commercialization Fellow at the Center for Biotechnology.\nStephen Chambers\, Managing Director of IndieBio in New York.\nMatthew McMahon\, Director of NIH’s Small Business Education and Entrepreneurial Development (SEED) Program.\nCameron Bess\, Project Officer\, Antibacterials Branch\, Division of CBRN Medical Countermeasures\, BARDA.\n\nTo learn more and register\, click here. 
URL:https://carb-x.org/event/building-funding-and-growing-successful-biotech-startups/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200919T090000
DTEND;TZID=America/New_York:20200919T100000
DTSTAMP:20260405T141524
CREATED:20200916T174934Z
LAST-MODIFIED:20200916T174934Z
UID:4347-1600506000-1600509600@carb-x.org
SUMMARY:Antimicrobial Resistance Fighter Coalition Webinar: Responding to difficult-to-treat infections: Role and responsibilities of governments\, researchers\, clinicians\, industry and patients
DESCRIPTION:AMR in the Light of COVID-19 – A Webinar Series\nEach of us is now living in a world with a nearly untreatable virus – but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to kill them. COVID-19 foreshadows a grim future if we do not mobilize a global response to the growing threat of antimicrobial resistance (AMR). Through a four-part series\, global experts will discuss how the COVID-19 pandemic could reshape strategies for combating antimicrobial resistance around the world. \nAbout this Webinar:\nGovernments\, researchers\, and industry partners around the world have mobilized to develop diagnostics\, therapeutics\, and vaccines for COVID-19. The development of new recommendations and practices continue to be deployed to slow the spread of COVID-19. The burden of drug-resistant infections could surpass COVID-19. Drugs like antibiotics are a vital tool for modern medicine\, used to prevent and treat infections. As drug-resistant infections are becoming more common\, modern medicine as we know it is at risk and much like COVID-19\, it has the potential to overwhelm our healthcare structure. What changes are needed to reshape strategies for combatting antimicrobial resistance globally? \nTo learn more about the Antimicrobial Resistance Fighter Coalition\, click here.\nTo learn more about this webinar series\, click here.\nTo register for this webinar\, click here.
URL:https://carb-x.org/event/antimicrobial-resistance-fighter-coalition-webinar-responding-to-difficult-to-treat-infections-role-and-responsibilities-of-governments-researchers-clinicians-industry-and-patients/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200922T070000
DTEND;TZID=America/New_York:20200922T080000
DTSTAMP:20260405T141524
CREATED:20200908T153527Z
LAST-MODIFIED:20200908T153553Z
UID:4314-1600758000-1600761600@carb-x.org
SUMMARY:Chatham House Webinar: Creating a New Generation of Antibiotics
DESCRIPTION:Participants include Kevin Outterson\, Executive Director of CARB-X. \nThe world needs a new generation of antibiotics to address the rapid growth in antibiotic-resistant bacteria. The UK government’s 2014 Review on Antimicrobial Resistance estimated that such bacteria could result in the deaths of 10 million people a year by 2050 and an accumulated cost of up to $100 trillion to the global economy. Despite this urgent need\, there remain few new antibiotics in development due to a lack of commercial viability for pharmaceutical companies with a 2019 Chatham House report highlighting the lack of progress being made on critical recommendations to tackle antimicrobial resistance. \nThis event will discuss the urgency of the development of new antibiotics and recent efforts to address the funding gap. What is the significance of the rise of antibiotic-resistant bacteria? What are the challenges at the intersection of increasing demand for new antibiotics and their commercial viability? Does the recent announcement of a new fund from the pharmaceutical industry represent a major shift\, or just the beginning\, of what is needed? \nParticipants: \n\nThomas Cueni\, Director General\, IFPMA\nJim O’Neill\, Chair\, Chatham House\nKevin Outterson\, Associate Fellow\, Global Health Programme\, Chatham House\nLaura Piddock\, Professor of Microbiology; Deputy Director of the\nInstitute of Microbiology and Infection\, University of Birmingham\nChair: Emma Ross\, Senior Research Fellow\, Global Health Programme\, Chatham House\n\nTo learn more\, click here.
URL:https://carb-x.org/event/chatham-house-webinar-webinar-creating-a-new-generation-of-antibiotics/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200923
DTEND;VALUE=DATE:20200926
DTSTAMP:20260405T141524
CREATED:20200820T183607Z
LAST-MODIFIED:20200820T183720Z
UID:4292-1600819200-1601078399@carb-x.org
SUMMARY:ESCMID Conference on Coronavirus Disease (ECCVID)
DESCRIPTION:Speakers include Kevin Outterson\, Executive Director of CARB-X. \nThe ESCMID Conference on Coronavirus Disease (ECCVID) will take place online from Wednesday 23rd to Friday 25th September 2020 and will cover all aspects of COVID-19. ECCVID will feature a comprehensive scientific programme that will span a wide range of topics surrounding this emerging threat.  \nCOVID-19 is a major public health incident which has brought about significant challenges and uncertainties with respect to diagnostics\, therapeutics and infection prevention and control. We are learning continually about the new SARS-CoV-2 virus and an international scientific event that brings together the latest research and scientific evidence is very timely. ECCVID will offer excellent opportunities to showcase the latest findings\, share experiences and knowledge and demonstrate practical techniques and guidance.  \nInternationally renowned clinical microbiologists\, infectious diseases specialists and experts from related disciplines will present their work and latest findings on COVID-19\, during the event. \nClick here to learn more.\nClick here to view the programme.\nClick here to register. \n 
URL:https://carb-x.org/event/escmid-conference-on-coronavirus-disease-eccvid/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T090000
DTEND;TZID=America/New_York:20200924T100000
DTSTAMP:20260405T141524
CREATED:20200916T174543Z
LAST-MODIFIED:20200916T174543Z
UID:4344-1600938000-1600941600@carb-x.org
SUMMARY:Antimicrobial Resistance Fighter Coalition Webinar: The global movement of microorganisms: Tracking the spread of difficult-to-treat infections
DESCRIPTION:AMR in the Light of COVID-19 – A Webinar Series\nEach of us is now living in a world with a nearly untreatable virus – but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to kill them. COVID-19 foreshadows a grim future if we do not mobilize a global response to the growing threat of antimicrobial resistance (AMR). Through a four-part series\, global experts will discuss how the COVID-19 pandemic could reshape strategies for combating antimicrobial resistance around the world. \nAbout this Webinar:\nTracking the spread of COVID-19 has been critical to the global public health response. This information allows hospitals to prepare for surges\, governments to deploy testing strategies\, and citizens to modify their behavior appropriately. But while information about COVID-19 is readily and publicly available\, the world still struggles to monitor and track the spread of drug resistant infections.How should global monitoring and data sharing evolve to combat antimicrobial resistance? \nTo learn more about the Antimicrobial Resistance Fighter Coalition\, click here.\nTo learn more about this webinar series\, click here.\nTo register for this webinar\, click here.
URL:https://carb-x.org/event/antimicrobial-resistance-fighter-coalition-webinar-the-global-movement-of-microorganisms-tracking-the-spread-of-difficult-to-treat-infections/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T093000
DTEND;TZID=America/New_York:20200924T113000
DTSTAMP:20260405T141524
CREATED:20200908T154818Z
LAST-MODIFIED:20200908T154944Z
UID:4319-1600939800-1600947000@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE – Moving from preclinical to clinical-stage: Challenges and opportunities
DESCRIPTION:Speakers: \n\nValue of a pre-IND interaction with the US FDA during late lead optimization: Bugworks experience – Bala Subramanian\, Bugworks Research Inc.\nAmicidins: Building clinical and regulatory strategies for non-traditional products to prevent and treat life-threatening infections – Michael P. Bevilacqua\, Amicrobe\, Inc.\nDiscovery and development of microbiome therapeutics using reverse translation – Matthew Henn & Chris Ford\, Seres\nTherapeutics Development of a multi-component toxoid vaccine for S. aureus – Regulatory challenges and opportunities – M. Javad Aman & Catherine Bernard\, Integrated BioTherapeutics\nRegulatory challenges for RaPID/BSI – culture-free identification and characterization of bloodstream infections – David Steinmiller\, HelixBind Inc.\n\nModerator: Erin Duffy\, CARB-X \nThe presentation will be followed by a Q&A session. \nRegister now for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-moving-from-preclinical-to-clinical-stage-challenges-and-opportunities/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200928
DTEND;VALUE=DATE:20201002
DTSTAMP:20260405T141524
CREATED:20200819T142611Z
LAST-MODIFIED:20200924T151406Z
UID:4283-1601251200-1601596799@carb-x.org
SUMMARY:World Vaccine Congress
DESCRIPTION:CARB-X speakers include Nadia Cohen\, Alliance Manager. \nThe World Vaccine Congress is an award-winning series of conferences and an exhibition that has grown to become the largest and most established vaccine meeting of its kind across the globe. Due to the global pandemic\, we have made a decision to run the 2020 congress VIRTUALLY. To mobilize\, coordinate and align funding to enable the research needed to tackle this crisis and stop the outbreak\, and commit with our experts how you can learn mechanisms for continuing scientific interactions and collaborations\, now and beyond the congress.\n  \nClick here to view the agenda.\nClick here to learn more.\nClick here to register. \nNadia Cohen will be participating in the panel\, World Vaccine Congress: Success case study 2 – Partnering with a non-profit for the first toxoid based multivalent vaccine for MRSA\, on September 29 at 2:40 pm – 3:10 pm ET.
URL:https://carb-x.org/event/world-vaccine-congress/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T090000
DTEND;TZID=America/New_York:20200930T121500
DTSTAMP:20260405T141524
CREATED:20200908T153930Z
LAST-MODIFIED:20200924T134830Z
UID:4317-1601456400-1601468100@carb-x.org
SUMMARY:Longitude Prize Sprint Workshop: How to Attract Investment
DESCRIPTION:Recent CARB-X graduate\, Specific Diagnostics\, will be participating in this workshop. \nThis workshop will be a forum for start-up and SMEs developing diagnostic tests to: \n\nHear from successful entrepreneurs who have built diagnostic companies\, what do they think were their key factors for success?\nHear from venture capital investors about what they expect and need before making investments.\nMeet in small break-out sessions in which you will interact directly with other medtech startups who have built or are in midst of building their enterprises and share insights.\nParticipate in panel discussion where you can ask both medtech leaders and venture capital fund managers about the intricacies and nuances of dilutive fund raise.\n\nNote: this webinar is the second in the Longitude Prize Sprint series. \nMore details can be found on the Longitude Prize website here. Registration is limited\, if you have trouble registering please send an email to longitude.prize@nesta.org.uk \nTo view the agenda\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/longitude-prize-sprint-workshop-how-to-attract-investment/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
END:VCALENDAR